Preventive effect of ginsenoid on chronic bacterial prostatitis

Journal of Infection and Chemotherapy

Volumn 18, Issue 5, 2012, Pages 709-714

  Kim, Sang Hoon ^a   Ha, U Syn ^a   Sohn, Dong Wan ^a   Lee, Seung Ju ^a   Kim, Hyun Woo ^a   Han, Chang Hee ^a   Cho, Yong Hyun ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Antibiotics; Chronic bacterial prostatitis; Ginsenoid; Prevention

Indexed keywords

ANTIINFECTIVE AGENT; CIPROFLOXACIN; GINSENOID; UNCLASSIFIED DRUG;

ACINAR CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIUM CULTURE; BODY WEIGHT; CELL INFILTRATION; CHRONIC PROSTATITIS; COLONY FORMING UNIT; COMBINATION CHEMOTHERAPY; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; ESCHERICHIA COLI; FIBROSING ALVEOLITIS; HISTOPATHOLOGY; INFECTION PREVENTION; MALE; MONOTHERAPY; NONHUMAN; RAT; URINALYSIS;

EID: 84871375334     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1007/s10156-012-0406-7     Document Type: Article

References (24)

1. Pfau A. Prostatitis. A continuing enigma. Urol Clin North Am. 1986;13:695-715.
2. Nickel JC, Olson ME, Costerton JW. Rat model of experimental bacterial prostatitis. Infection. 1991;19(Suppl 3):S126-30.
3. Stamey TA, Meares EM Jr., Winningham DG. Chronic bacterial prostatitis and diffusion of drugs into prostatic fluid. J Urol. 1970;103:187-94.
4. Nickel JC. Antibiotics for bacterial prostatitis. J Urol. 2000;163:1407.
5. Song ZJ, Johansen HK, Faber V, Hoiby N. Ginseng treatment enhances bacterial clearance and decreases lung pathology in athymic rats with chronic P. aeruginosa pneumonia. APMIS. 1997;105:438-44.
6. Ahn JY, Song JY, Yun YS, Jeong G, Choi IS. Protection of Staphylococcus aureus-infected septic mice by suppression of early acute inflammation and enhanced antimicrobial activity by ginsan. FEMS Immunol Med Microbiol. 2006;46:187-97.
7. Park EK, Choo MK, Han MJ, Kim DH. Ginsenoside Rh1 possesses antiallergic and anti-inflammatory activities. Int Arch Allergy Immunol. 2004;133:113-20.
8. Matsuda H, Samukawa K, Kubo M. Anti-inflammatory activity of ginsenoside ro 1. Planta Med. 1990;56:19-23.
9. Yu SC, Li XY. Effect of ginsenoside on IL-1 beta and IL-6 mRNA expression in hippocampal neurons in chronic inflammation model of aged rats. Acta Pharmacol Sin. 2000;21:915-8.
10. Seo SI, Lee S, Kim JC, Choi Y, Sw SW, Hwang TK, Cho Y. Effects of androgen deprivation on chronic bacterial prostatitis in a rat model. Int J Urol. 2003;10:485-91.
11. Han CH, Yang CH, Sohn DW, Kim SW, Kang SH, Cho YH. Synergistic effect between lycopene and ciprofloxacin on a chronic bacterial prostatitis rat model. Int J Antimicrob Agents. 2008;31(S1):S102-7.
12. Lee YS, Han CH, Kang SH, Lee S, Kim SW, Shin OR, Sim Y, Cho Y. Synergistic effect between catechin and ciprofloxacin on chronic bacterial prostatitis rat model. Int J Urol. 2005;12:383-9.
13. Sohn DW, Han CH, Jung YS, Kim SI, Kim SW, Cho Y. Antiinflammatory and antimicrobial effects of garlic and synergistic effect between garlic and ciprofloxacin in a chronic bacterial prostatitis rat model. Int J Antimicrob Agents. 2009;34:215-9.
14. Jantos C, Altmannsberger M, Weidner W, Schiefer HG. Acute and chronic bacterial prostatitis due to E. coli. Description of an animal model. Urol Res. 1990;18:207-11.
15. Moon TD. Questionnaire survey of urologist and primary care physicians' diagnostic and treatment practices for prostatitis. Urology. 1997;50:543-7.
16. Terai A, Yamamoto S, Mitsumori K, Okada Y, Kurazono H, Takeda Y, et al. Escherichia coli virulence factors and serotypes in acute bacterial prostatitis. Int J Urol. 1997;4:289-94.
17. Neal DE Jr., Moon TD. Use of terazosin in prostatodynia and validation of a symptom score questionnaire. Urology. 1994;43:460-5.
18. Nicolle LE. Uncomplicated urinary tract infection in adults including uncomplicated pyelonephritis. Urol Clin North Am. 2008;35:1-12.
19. Wagenlehner FM, Weidner W, Naber KG. An update on uncomplicated urinary tract infections in women. Curr Opin Urol. 2009;19:368-74.
20. Xie X, Eberding A, Madera C, Fazli L, Jia W, Goldenberg L, et al. Rh2 synergistically enhances paclitaxel or mitoxantrone in prostate cancer models. J Urol. 2006;175:1926-31.
21. Kim HS, Lee EH, Ko SR, Choi KJ, Park JH, Im DS. Effects of ginsenosides Rg3 and Rh2 on the proliferation of prostate cancer cells. Arch Pharm Res. 2004;27:429-35.
22. Song Z, Johansen HK, Faber V, Moser C, Kharazmi A, Rygaard J, et al. Ginseng treatment reduces bacterial load and lung pathology in chronic Pseudomonas aeruginosa pneumonia in rats. Antimicrob Agents Chemother. 1997;41(5):961-4.
23. Yang G, Bao T, Fu N, Geng P. Preliminary study of the modulating effects of ginseng on immunity in vivo and in vitro. Acta Bethune Med Univ. 1983;9:1-4 (in Chinese
24. Yang G, Bao T,YuY. Immunemodulating effects of ginseng in vivo and in vitro. Commun Med Res. 1987;16:220-1 (in Chinese).